Research ArticleClinical
What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus
Journal of Nuclear Medicine March 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
Guy-Anne Turgeon
1Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Amir Iravani
2Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Tim Akhurst
2Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Alexis Beaulieu
2Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Jason W. Callahan
2Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Mathias Bressel
3Department of Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Aidan J. Cole
1Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
4Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, Northern Ireland
Sarah J. Everitt
5Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and
6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Shankar Siva
1Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Rodney J. Hicks
2Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
David L. Ball
1Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Michael P. Mac Manus
1Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
6Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball, Michael P. Mac Manus
Journal of Nuclear Medicine Mar 2019, 60 (3) 328-334; DOI: 10.2967/jnumed.118.214148
What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball, Michael P. Mac Manus
Journal of Nuclear Medicine Mar 2019, 60 (3) 328-334; DOI: 10.2967/jnumed.118.214148
Jump to section
Related Articles
Cited By...
- No citing articles found.